NEW YORK, Feb. 17 (GenomeWeb News) - Shares of Beckman Coulter were down $3.36, or 5.59 percent, at $56.80 in mid-afternoon trading after the company reported a 5-percent drop in fourth-quarter sales.
As GenomeWeb News reported this morning, sales fell by 5.4 percent in the fourth quarter to $655.5 million from $693 million during the year-ago period.
Fourth-quarter consumable sales were up 12 percent, with acquisitions contributing to 3.9 percent of that growth.
Net income for the period decreased 70 percent to $17.8 million from $59.8 million during the fourth quarter of 2004.